Opening book details…
Can I read Cytokines of the Interleukin-6 Family as Emerging Targets in Inflammatory Bowel Disease on EtoBox?
Cytokines of the Interleukin-6 Family as Emerging Targets in Inflammatory Bowel Disease by Christoph Garbers; Juliane Lokau is a Biochemistry, Genetics and Molecular Biology article available to read on EtoBox.
What is Cytokines of the Interleukin-6 Family as Emerging Targets in Inflammatory Bowel Disease about?
Introduction: Inflammatory bowel disease (IBD) is an umbrella term that includes different chronic inflammatory diseases of the gastrointestinal tract, most commonly Crohn's disease and ulcerative colitis. IBD affects more than 6 million people worldwide and constitutes not only a debilitating disease for the patients, but also a significant factor for society due to costs for health care and reduced working capacity. Despite the introduction of biologicals for the treatment of IBD, the identification of novel targets that could lead to novel therapeutics is still needed. Areas covered: In this review, we summarize current knowledge about the interleukin-6 family of cytokines as potential therapeutic targets for improving the therapy of patients with IBD. We discuss cytokines like IL-6 itself for which therapeutics such as inhibitory monoclonal antibodies have already entered the clinics, but also focus on other family members whose therapeutic potential has not been explored yet. Expert opinion: The different cytokines of the IL-6 family offer multiple therapeutic targets that can potentially be used to treat patients with inflammatory bowel disease, but unwanted side effects like
Who reads Cytokines of the Interleukin-6 Family as Emerging Targets in Inflammatory Bowel Disease?
It is typically read by researchers, students, and practitioners in Biochemistry, Genetics and Molecular Biology.
- Author
- Christoph Garbers; Juliane Lokau
- Publisher
- Informa UK Limited
- Published
- 2024
- Language
- EN
- Field
- Biochemistry, Genetics and Molecular Biology (Life Sciences)